Schedule 13G ownership disclosure

180 Life Sciences Corp.

Common Stock · CUSIP: 68236V104

Event date: 2025-10-13

Filing-level shares
8,155,741.14
Percent of class
5.1%
  • Pemble Brian James

    Shares: 8,155,741.14 · Class: 5.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002088659-25-000003
Form type
SCHEDULE 13G
Filer
FORUM MARKETS Inc
CIK
CIK 1690080
Filed
Oct 15, 2025
Reporting period
Oct 13, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub